Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present CALCOL, Inc. (OTC: CLCL).

Full DD Report for CLCL

You must become a subscriber to view this report.



About CALCOL, Inc. (OTC: CLCL)

Logo for CALCOL, Inc. (OTC: CLCL)

THE COMPANY IS A DELAWARE USA HOLDING COMPANY WITH CHINA AND BVI SUBSIDIARIES FOR US AND CHINA INVESTMENTS IN SOFT DRINKS, ENERGY DRINKS AND PHARMACEUTICALS WITH OFFICES IN BEIJING, CHINA, AND BEACHWOOD, OHIO USA. THE COMPANY OWNS AND OPERATES MALIBU COLA BEVERAGE CO. LTD. CHINA BEIJING AND KULONG ENERGY BEVERAGE COMPANY INC. BVI WHICH MAKES AND SELLS ITS TRADEMARKED MALIBU COLA PRODUCED UNDER LICENSE FROM RC COLA INTERNATIONAL DIVISION OF COTT BEVERAGES USA INC. , MALIBU SUNRISE ORANGE, MALIBU SURFS UP LEMON LIME, MALIBU LEMON SQUEEZE, AND MALIBU DIET COLA IN CHINA. THE COMPANY HAS SUCCESSFULLY MARKETED ITS TRADEMARKED MALIBU BRANDED PRODUCTS IN CHINA THROUGH SALES CONTRACTS WITH WAL MART, TRUST MART, LOTUS, TESCO, CARREFOUR, AND OTHER MAJOR RETAIL CHAINS AS WELL AS LOCAL SUPERMARKETS. THROUGH ITS SUBSIDIARY COMPANIES, BEIJING KULONG ENERGY TRADING CO. LTD. AND KULONG ENERGY BEVERAGE COMPANY INC. BVI , THE COMPANY ALSO MANUFACTURES ITS OWN PROPRIETARY RECIPES AND SOLELY OWNED INTERNATIONALLY TRADEMARKED KULONG FRUIT FLAVORED VITAMIN DRINK WITH GUARANA, TAURINE, B VITAMINS, AND FRUIT FLAVORS FOR SALE IN CHINA, AND KULONG VITAMIN ENRICHED ENERGY DRINK WITH CAFFEINE, GUARANA, TAURINE, GLUCOURONOLACTONE, GINSENG, ACAI FRUIT, GOJI BERRY, MANGOSTEEN,B VITAMINS, ELECTROLYTES, AND FRUIT FLAVORS FOR SALE IN THE USA AND INTERNATIONALLY EX CHINA .THE COMPANY CURRENTLY MANUFACTURES IN USA AND PLANS TO DISTRIBUTE KULONG ENERGY DRINK AND KULONG ENERGY DRINK ZERO IN USA LABELLED MADE IN USA THROUGHOUT THE USA, CANADA, MEXICO, CENTRAL AND SOUTH AMERICA, CARIBBEAN, ALL OF EU, JAPAN AND HONG KONG AND TAIWAN, ISRAEL AND THE MIDDLE EAST. THE COMPANY ALSO OWNS A METHOD OF PRODUCTION OF CHEMICALLY SYNTHETIC LARGE SCALE GMP PHARMACEUTICAL GRADE DELTA TETRAHDYROCANNABINOL THC AND DELTA TETRAHYDROCANNABINOL CBD , AND OWNS THE DISTRIBUTION RIGHTS. THE COMPANY IS PLANNING FURTHER RESEARCH OF THC AND CBD PHARMACEUTICALS WITH THE OBJECTIVE TO DEVELOP FOR MANUFACTURE AND SALE A DOSAGE FORM AND MEDICAL DEVICE FOR PRECISE CLINICAL ADMINISTRATION BY PRESCRIPTION OF THESE MEDICATIONS FOR TREATMENT OF VARIOUS MEDICAL CONDITIONS.

 

Contact Information

 

 

Current Management

  • Norman Kaplan / CEO
  • David Orlean / Corporate Secretary, Treasurer
  • Jiangong Xiao / EVP
  • Norman Kaplan / Chairman
  • David Orlean /
  • Jiangong Xiao /

Current Share Structure

  • Market Cap: $1,999,511 - 03/16/2018
  • Authorized: 100,000,000 - 03/15/2018
  • Issue and Outstanding: 99,975,556 - 03/15/2018

 



Daily Technical Chart for (OTC: CLCL)

Daily Technical Chart for (OTC: CLCL)


Stay tuned for daily updates and more on (OTC: CLCL)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: CLCL)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

OTC Report
@OTCReporter

 

 


Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CLCL is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of CLCL and does not buy, sell, or trade any shares of CLCL. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/